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Abstract 
 
The susceptibility of the primary chick embryo chorioallontoic membrane cells to infectious bronchitis virus was evaluated 
after  twenty  consecutive  passages  in  chick  embryo  chorioallontoic  membrane  cells.  Virus  replication  was  monitored  by 
cytopathic observation, indirect immunoperoxidase, and reverse transcription polymerase chain reaction (RT-PCR). At 72 
hours  post-infection  (p.i.)  in  third  passage,  the  cytopathic  effect  was  characterized  by  rounding  up  of  cells,  monolayer 
detachment, intracytoplasmic brownish colouration was readily observed by immunoperoxidase from 24 hours p.i in third 
passage, and at all times the extracted viral RNA from IBV-infected monolayers was demonstrated by RT-PCR. Tissue culture 
ineffective dose50 (TCID50) was used to measure virus titration performed on primary chick embryo chorioallontoic membrane 
cells and the titre in twenty passage was 10
8.6 TCID50/ml. The results obtained in this study suggested that the primary chick 
embryo chorioallontoic membrane cells can be used for adaptation infectious bronchitis virus (IBV) and may be considered a 
step forward for the use of these cells in the future for IBV vaccine production 
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Introduction 
 
Infectious bronchitis virus (IBV) infects the respiratory 
tract, kidneys and oviduct of chickens of all ages, causing 
retarded  growth,  mortality,  reduced  egg  production  and 
inferior egg shell quality and in many countries the disease 
remains  one  of  the  main  problems  affecting  existing  or 
developing poultry industries. Until now, there is no cure 
for  the  disease  (1).  Prevention  is  to  import  birds  from 
disease-free flocks only or through vaccination, broilers are 
normally vaccinated at 1 day  of age  with live attenuated 
vaccines (2). In addition, breeders and egg layers are also 
vaccinated  at  approximately  8  week  intervals  with  live 
attenuated  vaccines,  and  with  inactivated  vaccines  after 
they start laying eggs (3). Acute Infectious bronchitis virus 
are usually detected by the indirect immunoperoxidase test, 
enzyme-linked  immunosorbent  assay,  virus  isolation  or 
serological approaches (4,5). However Infectious bronchitis 
virus infections can also be diagnosed by detection of viral 
RNA  by  RT-PCR,  which  make  the  diagnostic  rapid  and 
also  dependable  (6,7).  Usually,  Infectious  bronchitis 
vaccines  have  been  produced  by  growing  vaccine  virus 
strains in embryonated chicken eggs. Infectious bronchitis 
virus is harvested from the allantoic fluid and used to create 
a vaccine, nevertheless this method has the disadvantages 
of being labour-dense, takes long time and requires large 
area for the incubation of eggs. Cell cultures on the other 
hand considered are more suitable and less expensive than 
eggs  and  also  convenient  to  inspect  microscopically  for 
indication of viral proliferation (5,8). There is therefore an 
urgent need to improve on the current Infectious bronchitis 
virus vaccines production technologies based chick embryo 
chorioallontoic membrane (CAM) cells. The development 
of cell-culture platforms as an alternative to the eggs for the 
manufacture of IBV vaccines is likely the most rapid and 
promising  solution  to  overcome  current  vaccines 
production. In this study, firstly we investigated here for the 
first  time  the  ability  of  IBV  to  grow  in  chorioallontoic 
membrane  cells  and  second  to  detect  titres  of  IBV  in 
chorioallontoic membrane cells plus the possibility to use 
these cells for vaccine production in the future  
 
Materials and methods 
 
Virus inoculation 
The  stock  of  IBV  was  originally  obtained  from  the 
Faculty of Veterinary Medicine, University Putra Malaysia. 
This  virus  was  isolated  from  the  allantoic  fluid  of 
embryonated  chicken  eggs.  Initially,  0.3  ml  of  the  virus 
stock was diluted in 30 ml of 10x PBS giving a dilution of 
1:100.  This  diluted  virus  was  used  to  inoculate  primary 
chick  embryo  chorioallontoic  membrane  cells.  Fully 
confluent 25 cm
2 flasks of cells were used for virus passage 
in an attempt to adapt the virus to replicate in these cells.  
Cells and media 
Primary  chick  embryo  chorioallontoic  membrane 
(CAM) cells were prepared from 9- to 10-day-old specific 
pathogenic  free  (SPF)  chick  embryo.  The  chorioallontoic 
membranes were collected, washed with phosphate buffer 
saline and digested with trypsin/EDTA. The reaction was 
stopped  by  adding  (Dulbecco’s  Minimal109  Essential 
Medium  (DMEM)  complete  growth  medium  (GIBCO 
Laboratories, USA) supplement with; 2.0 g NaHCo3, 10% 
fetal  calf  serum  (FCS)  and  1%  antibiotic  of  penicillin-
streptomycin. After centrifugation at 1000 g for 10 min, the 
chorioallontoic  membrane  cells  were  resuspended  in  the 
same  medium  and  filtered  through  sterile  gauze.  The 
chorioallontoic  membrane  cells  in  the  filtrate  were 
distributed on plastic tissue culture flasks and incubated at 
37 °C with 5 % CO2. 
 
Tissue culture infective dose 50 (TCID50)  
The infectivity of replicate infectious bronchitis virus to 
chorioallontoic  membrane  cells  were  determined  by 
calculating  50%  end  point,  as  described  by  Reed  and 
Muench (9). Ten-fold serial dilution of IBV was prepared 
in phosphate buffer saline phosphate buffer saline from 10
-1 
to  10
-10.  A  96  well  tissue  culture  microtiteration  plate 
(Titertek,  UK)  was  used  to  prepare  chorioallontoic 
membrane cells monolayers. A 100 µl of each virus dilution 
was added in each well of first row leaving last two wells as 
negative  control.  The  plate  was  incubated  at  37°C  for  1 
hour  to  allow  adsorption.  Then  100  µl  of  prewarmed 
maintenance  medium  was  added  in  each  well  and  again 
incubated at 37°C in 5% CO2. The plate was observed twice 
daily  for  CPEs.  The  cells  were  stained  with  1%  crystal 
violet solution to determine the CPE. The highest dilution 
of virus showing 50% CPEs was considered as end point to 
calculate TCID50/ml.  
 
Indirect Immunoperoxidase Staining Test 
The  indirect  immunoperoxidase  test  (IIP)  was  done 
according to the method of de Wit et al. (4). The infected 
chorioallontoic  membrane  cells  were  fixed  with  cold 
methanol:  acetone  (50:50  volum/volum)  for  5  mins.  The 
glass slides were then immersed in 1% hydrogen peroxide 
in  absolute  methanol  for  30  mins.  The  phosphate  puffer 
salain was then added to the glass slide for 15 mins. The 
glass slides were then air dried. The hyper immune serum 
was diluted 1:1000 with PBS and added to the glass slide 
incubated for 1 hour in room temperature. The glass slides 
were then washed 3 times with phosphate puffer salain for 
5 mins each. The rabbit anti-chicken IgG-HRP conjugated 
secondary antibody (Bio-Rad, USA) was then added to the 
glass  slides  (1:1000)  and  incubated  for  1  hour  at  room Iraqi Journal of Veterinary Sciences, Vol. 27, No. 1, 2013 (33-37) 
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temperature.  DAB  substrate  solution  (DAB  reagent  set, 
Invitrogen, USA)  was then added to the glass slides and 
incubated for 10 minutes in a dark room. The slides were 
mounted  with  buffer  glycerol  and  examined  under  light 
microscope. 
 
RNA isolation 
RNA was isolated from infected cells using commercial 
RNeasy Mini Kit (Qiagen, USA) as recommended by the 
supplier. 
 
Reverse  transcription  polymerase  chain  reaction  (RT-
PCR) 
For RT-PCR the infected monolayers were submitted to 
detect  IBV  replication,  the  partial  spike  (S1)  gene  (1025 
nucleotides) of IBV was amplified RT-PCR after different 
passages according to the manufacturer’s recommendation 
(Takara).  The  specific  primers  for  IBV  S1  gene  were 
designed  according  to  IBV  H52  sequence  (accession 
number  AF3523151)  as  follows:  forward,  5-
CTATGTAGTGCTGTTTTG-3  (nucleotides  42  to  59); 
reverse,  5-CCTTGAAGAGG  ACCGTAA-3  (nucleotides 
1049 to 1066), and the RT-PCR was run 30 min at 50
0C 
and 2 min at 94
0C for one cycle, then 30 cycles of 30 sec at 
94
0C, 30 sec at 55
0C, 1.5 min at 72
0C, followed by 15 min 
at 72
0C (PTC-100TM Programmable Thermal Controller; 
MJ Research, Inc.) (6).  
 
Detection of PCR products  
PCR products were separated in 1.5% agarose gel in 1 x 
TAE buffer stained with ethidium bromide, compared with 
molecular mass marker and visualized by ultraviolet (UV) 
transillumination. 
 
Results  
 
Cytpopathic effect (CPE)  
Infected cell monolayer steadily became broken as the 
virus proliferates to occupy extra cells in culture. In the first 
and  second  passage, the  infectivity  was  sluggish and not 
very  clear  as  the  virus  was  just  begin  to  adapt  on  cells. 
Through  the  third  passage,  we  were  able  to  visualize 
cytopathic effect but it was not whole (localized) the cells. 
During the fourth and fifth passage, cytopathic effect was 
rapid  and  detached  in  two  days.  It  was  characterised  by 
rounding of cells, failure of cell adhesion, vacuolization in 
cells, clustering of infected cells (Figure 1).  
 
Virus titration 
The infectivity titre of the virus was found to increase 
gradually from the 5th to the 20
th passage. The TCID50 titre 
was 8.6 after 20 passages (Table 1). 
 
Indirect Immunoperoxidase Staining Test (IIPS) 
In  IIPS,  brown  complexes  were  seen  as  brownish 
intracytoplasmic granules around the nucleus (Figure 2) in 
infected  chick  chorioallontoic  membrane  cells  cultures 
treated with IBV antiserum, but such effects was not seen in 
control cell cultures. 
 
RT-PCR 
RT-PCR of different passages at passages 2, 5, 10, 15 
and  20  were  performed.  The  expected  1025  bp  was 
obtained for each passage examined (Figure 3).  
 
Table1: Virus titer determined by Tissue Culture Infective 
Dose50 (TCID50). 
 
Virus category and passage level   Virus titre TCID50/ml 
Virulent-unadapted   _ 
5  6.5 
10  7.4 
15  8 
20  8.6 
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Figure 1: (A) Uninfected control CAM cells monolayer. (B) 
Cytopathic effect of IBV isolate of the 3
rd passage at day 5 
pi. The arrows show detachment of cells from the substrate 
with the eventual destruction of the entire monolayer. 10 x. 
Bar = 200 µm. 
 
 
 
 
Figure 2: Identification of IBV in CAM cells culture using 
infected  cell  cultures  stained  with  HRP-conjugated 
antibody.  (A)  Uninfected  control  CAM  cells.  (B)  CAM 
cells infected with IBV at 3
rd passage at day 5 pi. The arrow 
shows the presence of specific intracytoplasmic brownish 
coloration IBV antigens. 10x. Bar = 100 µm. 
 
Discussion  
 
Infectious bronchitis (IB) virus, early described in 1930 
(10), continues to be a main cause of disease in chickens of 
all  ages  and types  in all  parts  of  the  world  (11,12). The 
disease  is  occurring  in  all  countries  with  a  concentrated 
poultry industry, with the occurrence of infection close to 
100% in most locations (13). Most of the countries rearing 
poultry commercially rely on vaccination to control IB, but 
the  vaccine  is  still  a  great  challenge  for  these  countries 
because of the wide variety serotypes for this virus. 
A  large  majority  of  the  vaccines  available  are  chick 
embryo–adapted  vaccines.  Cell  cultures  provide  a  useful 
alternative system for the virus preparation and adaptation, 
and find a suitable cell culture for IBV (14). 
 
 
 
Figure  3:  S1  gene  (1025  pb)  of  IBV.  Lane  1  Negative 
control; Lane 2 positive passage 2; Lane 3 positive passage 
5: Lane 4 passage 10; Lane 5 positive passage 15 and Lane 
6 positive passage 20 ; M- 100 bp DNA marker (Promega, 
USA).  
 
In the present study, attempts were made to adaptation 
IBV isolate by blind passage first in SPF embryos (15) and 
then  adapted  to  the  CAM  cells  until  20
th  passages.  The 
cytopathic  effects  (CPEs)  appeared  after  72  hours  of 
infection  in  third  passage  and  this  observation  was  also 
noticed  by  (16),  but  slightly  varied  from  findings  of 
Mahgoub et al. (12) where the IBV was adapted to Vero 
cell line after the third passage.  
The difference might be due to the cell culture passage 
level of the virus strains used or variation in sensitivity of 
cell culture to different strains. 
 The total infectious titer passage 20 was found to be 
10
8.6TCID50/mL. These finding supports the previous report 
by (17) as they found titer 10
9
 TCID50/mL in passage 25 in 
Vero cells.  
The  classical  method  of  detecting  adaptation  and 
replication  of  IB  virus  in  the  cell  culture  using  the 
cytopathic effect was augmented in this study with indirect 
immunoperoxidase  is  a  relatively  inexpensive  and  rapid 
method  (18).  Monoclonal  antibody  (Mab)  reacting  only 
with one or small number of epitopes of the IBV antigen, Iraqi Journal of Veterinary Sciences, Vol. 27, No. 1, 2013 (33-37) 
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results  in  viral  antigen  was  observed  as  brownish 
intracytoplasmic granules in CAM cells (18).  
RT-PCR  has  been  used  widely  as  a  rapid,  sensitive, 
specific,  and  high  throughput  methodology  for  fast 
detection  of  genetic  materials.  This  method  was  used 
successfully for detection of IBV (6,7). In this study RT-
PCR  performed  for  viral  RNA  extracted  from  infected 
CAM cells to amplify of 1025 bp. The use of this technique 
for virus detection has been reported previously (4). 
The conclusion of this study that CAM cells have used 
for  the  first  time  to  isolate  and  adapt  IBV  successfully 
which could open new horizons to use these cells for the 
vaccine production in the future. 
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